期刊文献+

多酚类化合物对白色念珠菌超微结构的影响 被引量:3

Effect of Phenolic Compounds on the Ultrastructure of Candida albicans
下载PDF
导出
摘要 目的 :电镜观察白色念珠菌与多酚类化合物作用后形态和超微结构的改变 ,进一步评价该类化合物的抗真菌作用 ,探讨其抗真菌作用机制。方法 :将临床新分离的白色念珠菌与多酚类化合物共同培养 2 4h后 ,分离菌体 ,按常规方法进行样品处理 ,在扫描电镜与透射电镜下观察其细胞表面形态结构变化与细胞内超微结构变化。结果 :扫描电镜下观察可见酚类化合物作用后的白色念珠菌 ,细胞表面皱缩不平 ,细胞壁膜有严重皱折、变薄、剥脱等现象 ,并且质地变脆 ,有裂纹形成。透射电镜下可见 ,细胞壁不完整 ,局部有缺损 ,质地疏松 ,厚薄不均 ;细胞膜轮廓不清 ,不连续 ,有凸起 ;胞质不均匀 ,细胞内成分聚集固缩成电子密度较高的团块 ,且形成大量电子密度高的光亮区 ,间成有电子光点和空胞状物。结论 :酚类化合物与白色念珠菌作用后 ,可使其超微结构发生明显的改变 ,此改变表明了其抗真菌作用 ,并为其抗真菌作用机制的研究提供了线索。 AIM:To observe the effects of phenolic compounds on the ultrastructure of Candida albicans and to find out the potential mechanism of their antifungal action. METHOD:The mixtures of phenolic compounds and Candida albicans were incubated at 35 ℃ in ambient air with agitation for 24 h. The ultrastructure of Candida albicans was observed under scanning electron microscope (SEM) and under transmission electron microscope (TEM). RESULT:After exposing to phenolic compounds,profound cell wall changes such as cell surface wrinkles,excoriation and fracture were noted under scanning electron microscope. The density of the cell wall decreased and the cell membrane became discontinuous with TEM observation. The cytoplasma aggregated and some high density electron light areas as well as vacuoles were formed. CONCLUSION:Phenolic compounds exerted potent impact on the ultrastructure of Candida albicans. The ultrastructural changes demonstrated the antifungal effects of tested compounds and provided the hint of the most potential mechanism of antifungal activities.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2005年第1期52-55,共4页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目 (No 3 0 2 715 3 7)~~
关键词 酚类化合物 白色念珠菌 扫描电镜 透射电镜 Phenolic compounds Candida albicans Scanning electron microscope Transmission electron microscope
  • 相关文献

参考文献14

  • 1李绣辉,马廉兰,曾祥风.白色念珠菌可能具有荚膜结构[J].中华微生物学和免疫学杂志,2000,20(3):202-203. 被引量:3
  • 2温旺荣,戴庚孙.念珠菌耐药性的研究进展[J].国外医学(临床生物化学与检验学分册),2001,22(1):38-39. 被引量:10
  • 3蒋庆锋,周有骏,盛春泉,王金政.作用于真菌细胞壁的抗真菌药物的研究进展[J].中国药学杂志,2003,38(6):410-413. 被引量:12
  • 4Chung SK,Lee KW,Kang HI,et al.Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents[J].Bioorg Med Chem,2000,8(10):2 475-2 486.
  • 5Abi-Said D,Anaissie E,Uzun O,et al.The epidemiology of hematogenous candidiasis caused by different Candida species[J].Clin Infect Dis,1997,24(6):1 122-1 128.
  • 6Douglas LJ. Candida biofilms and their role in infection[J].Microbiology,2003,11(1):30-36.
  • 7Kontoyiannis DP,Lewis RE. Antifungal drug resistance of pathogenic fungi[J].Lancet,2002,359(9312):1 135-1 144.
  • 8Baumgartner C,Freydiere A,Gile Y. Direct identification and recognition of yeast species from clinical material by using albicans ID and chromagar Candida plates[J].J Clin Microbiol,1996,34(2):454-456.
  • 9Fricker-Hidalgo H,Vandapel O,Duchesne MA,et al. Comparison of the new API Candida system to the ID 32 C system for the identification of clinically important yeast species[J].J Clin Microbiol,1996,34(7):1 846-1 848.
  • 10Pfaller MA,Houston A,Coffman S. Application of chromagar Candida for rapid screening of clinical specimens for Candida albicans,Candida tropicalis,Candida krusei and Candida (Torulopsis) glabrata[J].J Clin Microbiol,1996,34(1):58-61.

二级参考文献39

  • 1孙荫 冯仁丰.细菌形态检查.实用医学检验学[M].上海:上海科学技术出版社,1996.592-593.
  • 2管远志 管德源.细菌的结构.医学微生物学(第4版)[M].北京:人民卫生出版社,1996,18..
  • 3林特夫 陆德源.主要病原性真菌.医学微生物学(第4版)[M].北京:人民卫生出版社,1996.210.
  • 4de Pauw B. ls there a need for new antifungal agents? [J ]. Clin Microbiol Infect, 2000,6 (Suppl 2) : 23.
  • 5Debono M,Gordee RS. Antibiotics that inhibit fungal cell wall development [ J ]. Annu Rev Microbiol, 1994,48.471.
  • 6Georgopapadakou NH. Update on antifungals targeted to the cell wall:focus on beta-l, 3-glucan synthase inhibitors [J]. Expert Opin Investig Drugs ,2001,10(2) :269.
  • 7Dehono M, Turner WW, LaGrandeur L, et al. Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B: structure-activity studies of the lipophilic and geometers of polyarylated acyl analogs of ECB[J]. J Mad Chem, 1995,38:3271.
  • 8Taft CS,Selitrennikoff CP. Cilofungin inhibition of ( 1,3)-β-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity[ J ]. J Antibiot, 1990,43 (4) : 433.
  • 9Keating GM, Jarvis B. Caspofungin [ J ]. Drugs, 2001,61 ( 8 ) :1121.
  • 10Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent,FK463, against a variety of clinically important fungi [ J ]. Antimicrob Agents Chemother , 2000, 44(1):57.

共引文献22

同被引文献21

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部